Cost Effectiveness and Utility of Computed Tomography Angiography (CTA) and Cardiac Cath

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Aine Kelly, MD, University of Michigan

ClinicalTrials.gov Identifier:

NCT00722813

First received: July 24, 2008

Last updated: November 20, 2013

Last verified: November 2013

History of Changes

Purpose

This is a research study to determine patient preferences between two different diagnostic tests; a CT angiogram (CTA) and a catheter angiogram, both of which are used at the University to screen for and detect heart disease.

Condition	Intervention
Heart Diseases	Other: Survey


Study Type:	Observational
Study Design:	Observational Model: Case Control Time Perspective: Prospective
Official Title:	Cost Effectiveness and Utility of Coronary Artery Computed Tomography Angiography (CTA) in Screening for Coronary Artery Disease

Resource links provided by NLM:

MedlinePlus related topics: Heart Diseases

U.S. FDA Resources

Further study details as provided by University of Michigan:

Primary Outcome Measures:

Utility of CT and catheter angiography [ Time Frame: Within 6 months of testing with CT and catheter angiography ]
Utility of CT and catheter angiography was compared within patients who had both tests performed.


Enrollment:	31
Study Start Date:	October 2006
Study Completion Date:	November 2012
Primary Completion Date:	October 2012 (Final data collection date for primary outcome measure)

Intervention Details:

To determine patient preference for the two tests CT angiography (CTA) and catheter coronary angiography (CCA).

Detailed Description:

This is a single site study that will retrospectively and prospectively identify and enroll 100 subjects, both male and female, 18 years of age and older who undergo both coronary angiography and coronary artery computed tomography (CT), using the electronic radiology and cardiology databases. The purpose is to conduct a survey to assess their preference for either test to diagnose coronary artery disease. Subjects should be within six months of having the tests to avoid memory and recall problems.

Eligibility


Ages Eligible for Study:	18 Years and older (Adult, Senior)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No
Sampling Method:	Probability Sample

Study Population

Subjects who have had both CTA and Cardiac catherizations

Criteria

Inclusion Criteria:

Subjects who have had both CTA and Coronary angiogram.
18 years old and older.

Exclusion Criteria:

Under 18 years of age
Memory Impairment:
- Stroke
- Traumatic brain Injury
- Dementia

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00722813

Locations


United States, Michigan
University of Michigan Health Systems
Ann Arbor, Michigan, United States, 48109

Sponsors and Collaborators

University of Michigan

Investigators


Principal Investigator:	Aine Kelly, MD	University of Michigan

More Information


Responsible Party:	Aine Kelly, MD, Primary Investigator, University of Michigan
ClinicalTrials.gov Identifier:	NCT00722813 History of Changes
Other Study ID Numbers:	HUM00003409
Study First Received:	July 24, 2008
Last Updated:	November 20, 2013

Additional relevant MeSH terms:


Heart Diseases Cardiovascular Diseases

ClinicalTrials.gov processed this record on May 25, 2017

To Top